Printer Friendly
The Free Library
19,585,946 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Agilent Technologies and Deltex Medical Announce Product Development Agreement for Non-invasive Cardiac Function and Volume Status.


Business Editors & High-Tech/Health/Medical Writers

PALO ALTO Palo Alto, city, California
Palo Alto (păl`ō ăl`tō), city (1990 pop. 55,900), Santa Clara co., W Calif.; inc. 1894. Although primarily residential, Palo Alto has aerospace, electronics, and advanced research industries.
, Calif. and CHICHESTER, England--(BUSINESS WIRE)--March 15, 2000

Agilent Technologies This article needs sources or references that appear in reliable, third-party publications. Alone, primary sources and sources affiliated with the subject of this article are not sufficient for an accurate encyclopedia article.  Inc. (NYSE NYSE

See: New York Stock Exchange
:A) and Deltex Medical today announced the signing of a product development agreement covering the connection of Deltex's CardioQ non-invasive cardiac function technology with Agilent V24/26 and CMS (1) See content management system and color management system.

(2) (Conversational Monitor System) Software that provides interactive communications for IBM's VM operating system.
 series patient monitors.

With this agreement, selected information generated by the Deltex CardioQ monitor will be displayed on the new and existing Agilent patient monitors via an Agilent VueLink module. Availability of this interface is expected later this year.

The CardioQ is a cardiac function monitor that measures blood flow non-invasively. The data provided supports diagnosis of the status and changes in the patient's cardiac performance and whole body fluid volume, providing immediate feedback on the results of therapeutic interventions. Continuous-wave Doppler ultrasound Doppler ultrasound
An imaging technique using ultrasound that can detect moving liquids.

Mentioned in: Priapism


Doppler ultrasound
 transducers, mounted at the tip of an easy-to-use, patient-dedicated esophageal esophageal /esoph·a·ge·al/ (e-sof?ah-je´al) of or pertaining to the esophagus.

esophageal

of or pertaining to the esophagus.


esophageal achalasia
see megaesophagus.
 probe, are used to monitor blood-flow signals from the patient's descending descending /des·cend·ing/ (de-send´ing) extending inferiorly.  aorta.

More than 65 clinical studies and articles have been published related to Deltex's esophageal Doppler technology. Several outcome studies utilizing Deltex's technology show that use of the monitor can reduce post-operative morbidity morbidity /mor·bid·i·ty/ (mor-bid´it-e)
1. a diseased condition or state.

2. the incidence or prevalence of a disease or of all diseases in a population.


mor·bid·i·ty
n.
 and length of hospital stay by over 30 percent.

Deltex has installed over 600 standalone stand·a·lone  
adj.
Self-contained and usually independently operating: a standalone computer terminal. 
 CardioQ, EDM/ODM monitors worldwide in over 300 hospitals. Agilent CMS Series monitors and V24/26 are part of the world's most popular patient monitoring family, with more than 180,000 installed around the world.

"Until now, clinicians have had no reliable or easy-to-use non-invasive indicator of their patient's fluid status and cardiac function," said Kemp Coady, group CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Deltex. "This is especially true for critically ill patients undergoing major surgery, those in the Intensive Care Unit, and trauma patients. The data provided by Deltex's technology bridges that gap in the monitoring armory. We are particularly excited by this new product development agreement with Agilent, as clinicians will now be able to integrate CardioQ data with other physiological data in Agilent bedside monitors, at central stations, and via networked Clinical Information Systems."

"This agreement is consistent with our strategy of interfacing new and innovative measurement technologies into our patient monitoring suite," said Tony Ecock, general manager of Agilent's Patient Monitoring Division. "By providing our customers with the ability to interface best-in-class, third-party products with their existing Agilent patient monitors, the overall cost of product integration is vastly reduced, making access to information across the healthcare delivery system more affordable."

About Agilent's Healthcare Solutions Group

Agilent's Healthcare Solutions Group is a worldwide leader in clinical measurement and diagnostic solutions for the healthcare industry. The group has 4,800 employees and had revenues of more than $1.5 billion in its 1999 fiscal year.

Agilent holds leading market share worldwide in patient monitoring, cardiovascular ultrasound ultrasound or sonography, in medicine, technique that uses sound waves to study and treat hard-to-reach body areas. In scanning with ultrasound, high-frequency sound waves are transmitted to the area of interest and the returning echoes recorded  imaging and for critical-care information-management systems. Information about Agilent's Healthcare Solutions Group can be found on the Web at www.agilent.com/healthcare/.

About Deltex Medical

Deltex Medical Holdings Limited is a rapidly emerging company funded by venture capital, that is based in the UK, with sales offices in the USA, and an international presence via independent distributors. The company designs, manufactures and markets a cardiac function status monitor measuring blood flow that allows diagnosis of changes in a patient's cardiac performance, providing immediate feedback on the effects of therapeutic interventions.

Information about Deltex Medical can be found on the Web at www.Deltex.com.

About Agilent Technologies

Agilent Technologies Inc. (NYSE:A) is a diversified technology company, resulting from Hewlett-Packard Company's plan to strategically realign re·a·lign  
tr.v. re·a·ligned, re·a·lign·ing, re·a·ligns
1. To put back into proper order or alignment.

2. To make new groupings of or working arrangements between.
 itself into two fully independent companies. With 42,000 employees serving customers in more than 120 countries, Agilent Technologies is a global leader in designing and manufacturing test, measurement and monitoring instruments, systems and solutions, and semiconductor and optical components. The company serves markets that include communications, electronics, life sciences and healthcare. The businesses comprising Agilent, a subsidiary of HP, had net revenues of more than $8.3 billion in fiscal year 1999.

Information about Agilent Technologies can be found on the Web at www.agilent.com.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Mar 15, 2000
Words:669
Previous Article:INVU Announces Corporate Financing Partnership With Allen & Co. Affiliate, Merrion Capital.
Next Article:Los Angeles County Education Foundation Receives $15,000 Grant From AirTouch; Donation to Fund Anger Management Training in 10 Los Angeles Schools.
Topics:



Related Articles
Deltex To Adapt Its Cardiac Function Monitors For Spacelabs Medical's Flexport System Interface.
Agilent Technologies Affirms Commitment to Diagnostic Cardiology With Pending Acquisition of Zymed; Deal To Augment Agilent's Portfolio of Cardiology...
CVS.com and Agilent Technologies Offer Life-Saving Portable Defibrillators to Consumers Through the Internet.
Ortivus Signs Agreements With Agilent Technologies Worth At Least USD 32 Million.
Novametrix Announces Agreement to Distribute Agilent Reusable Oximetry Sensors.
Agilent Technologies Named Exclusive U.S. Distributor of Cambridge Heart's CH2000 Cardiac Stress-test System.
Agilent Technologies Debuts Breakthrough Point-of-Care Ultrasound Device.
Agilent Technologies and PULSION Medical Systems Introduce Hemodynamic Assessment Tool to U.S. Market.
Bioimpedance-derived differences in cardiac physiology during exercise stress testing in low-risk chest pain patients.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles